Cathal is a Senior Lecturer in Pharmacology and Therapeutics in UCC.Cathal is Principal Investigator of both the HRB-funded COMRADES Study: MitoChondrial DysfunctiOn and Metainflammation in PRe-eclampsiA and Gestational Diabetes Mellitusand the HRB-funded DIVINE study; “Dysfunctional mItochondria proVokes Inflammation iN prEeclampsia”I graduated with a B.Sc. Microbiology from University College Cork. I undertook my Ph.D studies in Vascular Biology in Dublin Institute of Technology, investigating the pathways modulating placental insufficiency in pre-eclampsia and IUGR. My postdoctoral studies in the School of Biomolecular and Biomedical Sciences in University College Dublin focused on the elucidation of novel atheroprotective networks mediating Conjugated Linoleic acid (CLA) induced regression of pre-established atherosclerosis using in vitro and in vivo models of disease. I joined INFANT in 2013 and the primary focus of my research is investigating the disruptive pathways causing pre-eclampsia and gestational diabetes mellitus and the development of novel therapeutics to effectively treat these pregnancy complications. Pre-eclampsia (PE) and gestational diabetes (GDM) are two common complications of pregnancy and Cathal’s research is interested in the role of mitochondrial dysfunction in utero in particular the redox and inflammatory signalling cascades. Cathal is also interested in exploring therapeutic strategies of directly targeting mitochondria and determining their capacity to mediate the sophisticated signalling networks of the adipose-placenta axis in pre-eclampsia and gestational diabetes mellitus.